2016 0923 Profectus Preclinical Data RALDH2 Mucosal Adjuvant
September 23, 2016 (HPV), herpes simplex virus type 2 (HSV-2), and human immunodeficiency virus (HIV). Partners and collaborators include Vyriad, the Galveston and the AIDS Clinical Trials Group. Profectus has been funded by Cross Atlantic Capital Partners ... Doc Viewer
2017 European Guideline For The Management Of Genital Herpes ...
2017 European guidelines for the management of genital herpes Institute of Clinical Medicine, University of Oslo, Oslo, Norway Abstract: First infection with either herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2) ... Fetch Here
Herpes Vaccine Research And News By 2017 - YouTube
" herpes vaccine " " herpes vaccines " " vaccine for herpes " " herpes vaccine research " " herpes vaccine news " " herpes vaccine 2017 update "2016 witnessed glimpses of hope of herpes simplex virus 1 and 2 has made it very phases of clinical trials. We are ... View Video
Antigenic Breadth: A Missing Ingredient In HSV-2 Subunit ...
Antigenic breadth: a missing ingredient in HSV-2 subunit vaccines? Expert Rev. Vaccines 13(6), 691–710 (2014) William P Halford Department of Microbiology and why HSV-2 glycoprotein subunit vaccines have failed in clinical trials, and why live HSV-2 ... Get Doc
Vical Document - S1.q4cdn.com
Candidates will be shown to be safe and efficacious in clinical trials and the other risks set forth in the company’s Annual Report Herpes simplex virus type 2 Phase 2 HSV-2 Trial Initiated 3Q 2016; ... Access Doc
Antivirals, Herpes Simplex Virus (HSV) - Idaho
Page 2 | Antivirals, Herpes Simplex Virus Antivirals, Herpes Simplex Virus (HSV) Review – December 2016 Proprietary Information. Restricted Access – Do not disseminate or copy without approval. several meta-analyses and clinical trials ... Fetch Doc
Varicella Vaccine - Wikipedia
Clinical data; Trade names: Varivax, Varilrix, other: AHFS/Drugs.com: Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. ... Read Article
Biomere History Vaccine Platform Components
HSV-2 therapeutic data in Guinea Pigs Massachusetts Medical School, Biomere operates as a preclinical Contract Research Organization (CRO) From 2002-2016, Biomere provided or obtained funding for A mucosal HSV-2 vaccine candidate for clinical trials Grant# 5R44AI063820-08 ... Doc Viewer
Protocol HPTN 039 - The HIV Prevention Trials Network
Requiring the retest of 10% of the HSV-2 positive enrollment samples Page 2 of 3 HPTN 039 Letter of Amendment #7, 09 February 2006 5.4 Follow-Up Visits: HIV Prevention Trials Network PROTOCOL CLARIFICAT ION MEMORANDUM #5 ... Read Content
Vaccine Development For Sexually Transmitted Infections
Vaccine Development for Sexually Transmitted Infections Sami Gottlieb, MD, MSPH Looker K et al, manuscript under review, 2016 . Neonatal Herpes Implications HSV Vaccines Currently in Clinical Trials Vaccine Company Candidate Adjuvant Current Phase ... Get Document
No comments:
Post a Comment